teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - mage-neoplasmer - antineoplastiske midler - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
bronwel comp -
kwizda pharma gmbh - timian / altearot - pastill
sedix -
tilman s.a. - pasjonsblomst - tablett, drasjert
pascoflair -
pascoe pharmazeutische präparate gmbh - pasjonsblomst - tablett, drasjert - 425 mg
airapy 100 %
linde gas - luft til medisinsk bruk - medisinsk gass, komprimert - 100 %
capsion sodium iodide [131i] capsules for therapy 50 mbq
cis bio international - natriumjodid (131 i) - kapsel, hard - 50 mbq
drytec tm -
ge healthcare b.v. - natriummolybdat mo-99 omdannes til natriumperteknetat tc-99m - radionuklidegenerator
mibg [123i] 74 mbq/ ml
curium netherlands b.v. - jobenguansulfat (123i) - injeksjonsvæske, oppløsning - 74 mbq/ ml
nanocoll -
ge healthcare as - albumin humant kolloidale partikler ad tc-99m albumin nanokolloid - pulver til injeksjonsvæske, suspensjon